What they were paid
LENZ Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $80,000 | $0 | $304,081 | $0 | $384,081 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LENZ Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001815776-26-000026, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025LENZ Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themNominating/Governance (Chair)
The rest of the LENZ Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Evert Schimmelpennink | Director | $0 |
| Frederic Guerard | Independent Director | $363,581 |
| James McCollum | Independent Director | $344,081 |
| Kimberlee C. Drapkin | Independent Director | $355,081 |
| Shelley Thunen | Independent Director | $365,081 |
| Zach Scheiner | Independent Director | $356,581 |
The full LENZ Therapeutics compensation record
free company briefThis page is one director within LENZ Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat